Chenguang Biotech Group (300138) — Capital Reinvestment Ratio
Chenguang Biotech Group (300138) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥524.96 Million) in capital expenditures (CN¥37.63 Million). Check tangible equity quality of Chenguang Biotech Group to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Chenguang Biotech Group Capital Reinvestment Ratio (2008–2022)
This chart tracks Chenguang Biotech Group's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see Chenguang Biotech Group (300138) cash conversion ratio.
Annual Capital Reinvestment Ratio for Chenguang Biotech Group (2008–2022)
Year-by-year Capital Reinvestment Ratio for Chenguang Biotech Group from 2008 to 2022. See Chenguang Biotech Group (300138) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.24x | CN¥734.81 Million | CN¥176.03 Million | ▼ -94.5% |
| 2021 | 4.39x | CN¥63.90 Million | CN¥280.82 Million | ▲ +432.5% |
| 2020 | 0.83x | CN¥529.41 Million | CN¥436.88 Million | ▲ +515.0% |
| 2014 | 0.13x | CN¥272.96 Million | CN¥36.62 Million | ▼ -93.9% |
| 2011 | 2.21x | CN¥82.18 Million | CN¥181.72 Million | ▼ -10.0% |
| 2009 | 2.46x | CN¥27.23 Million | CN¥66.90 Million | ▼ -14.5% |
| 2008 | 2.87x | CN¥9.06 Million | CN¥26.05 Million | — |